Articles On Telix Pharmaceuticals (ASX:TLX)

Every now and again, an ASX company emerges that captures the hearts and minds of investors.  It doesn't happen every year, but it certainly happens more often than you think.  From Droneshield (ASX: DRO) to ProMedicus (ASX: PME) to S...

ASX heath sector up 1.9%, trailing ASX 200’s 2% gain in short week revival   Sleep-related respiratory disorders company ResMed reports “stronger than expected” Q3 FY25 results Imricor makes key regulatory strides in Q1 CY25, including sub...

On Wednesday, the S&P/ASX 200 Index (ASX: XJO) was on form and stormed higher. The benchmark index rose 1.3% to 7,920.5 points. Will the market be able to build on this on Thursday? Here are five things to watch: ASX 200 expected to r...

Key Highlights: Examine the role of global economic shifts on stocks like BHP Group (ASX:BHP) and Coles Group (ASX:COL) in the ASX. Review sector performances with a focus on gains in energy and mixed results in materials. H...

Highlights: ASX lifted by gains in energy and tech sectors following tariff updates from the US Gold miners dragged by falling spot gold prices after record highs Capricorn Metals and BHP moved on executive updates, while Pa...

The S&P/ASX 200 Index (ASX: XJO) enjoyed a hump day boost this Wednesday, rocketing higher following a surge of optimism out of the United States. By the time trading wrapped up today, the ASX 200...

Trump backs off tariffs and markets breathe easier Musk will spend more time at Tesla after a shocker quarter Gold miners smashed as traders cash in on record highs   The ASX rallied by about 1.5% on Wednesday, riding a wave of optimism f...

Highlights: The ASX200 advanced sharply, led by gains in the energy and health care sectors Uranium-related shares recorded significant upward movements during the session Gold miners faced pressure amid a shift in sentiment...

Highlights ASX rises strongly amid optimism over easing US-China trade tensions Energy and healthcare sectors post notable gains during early trade Gold segment experiences downturn as risk appetite shifts The Australi...

Highlights: ASX 200 index advanced, supported by mining and pharmaceutical sector developments. Paladin Energy and Telix Pharmaceuticals reported operational and financial updates. Trigg Minerals appointed new leadership to...

The ASX 200 has been in a positive mood today, up 1.60% at 7,941 points in early afternoon trades. Paladin Energy (ASX:PDN) has been among the most watched on the HotCopper forums this morning. The stock has risen by more than 25% on new...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 1.6% to 7,942.8 points. Four ASX shares that are rising more than most today are listed below....

Highlights ASX surges on hopes of tariff relief and Wall Street momentum Energy, tech, and mining stocks lead gains; gold stocks retreat Paladin Energy shines with record uranium output Australian shares rallied strongly mid-week,...

It's a great day on the S&P/ASX 200 Index (ASX: XJO) today. At the time of writing, the benchmark Aussie index is up 1.6% at 7,939.1 points. ASX 200 uranium stock Paladin Energy Ltd (ASX: PDN) is leading the charge, with shares up 21.6%...

Highlights  ASX jumps nearly 2% on Wall Street rally and US tariff rollback signals  Resource and tech stocks post strong gains amid easing trade concerns  Telix, Paladin shine with major updates; Cettire tumbles on weak demand  A...

Telix’s quarterly sales reflect first revenue from the company’s recent purchase of a US nuclear medicine manufacturer Island Pharma hopes to lift the kimono on its dengue fever trial next month Race Oncology kicks off its cancer-busting,...

Highlights  ASX opens with a sharp gain following Wall Street momentum  Paladin Energy leads with record quarterly output  Gold stocks retreat as prices peak above $US3500/oz  Australian shares climbed sharply in early trade, lift...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are catching the eye on Wednesday morning. At the time of writing, the ASX 200 biotech company's shares are up 15% to $28.95. Telix shares rocket on Q1 update Investors have been buying the compan...

Highlights  ASX 200 futures rise over 1.2% following a broad-based US market rebound  Global sentiment boosted by signs of progress in trade negotiations with Japan and India  Gold stocks ease, while growth-oriented sectors and tech E...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) started the shortened week with a small decline. The benchmark index edged slightly lower to 7,816.7 points. Will the market be able to bounce back from this on Wednesday? Here are five thi...

Highlights: Nextdc operates data centres across the Asia-Pacific, supporting cloud and AI infrastructure Telix Pharmaceuticals develops radiopharmaceuticals for oncology imaging and therapy Both companies continue to expand...

If you are lucky enough to have $10,000 to invest and also have a penchant for ASX growth shares, then read on! That's because listed below are three fantastic shares that analysts are tipping to grow strongly in the coming years. Here's wh...

Highlights James Hardie Industries continues to benefit from rising demand for fibre cement in North America ResMed maintains market presence with its respiratory care product portfolio and recurring revenue base Telix Pharm...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 /PRNewswire/ — Telix Pharma...

If you are on the lookout for some investment ideas, then it could be worth checking out what analysts saying. Listed below are five ASX 200 stocks that leading brokers currently rate as buy. Here's what they are recommending to clients: J...

With markets still struggling for direction, now might be the ideal time for long-term investors to focus on quality — and there's no shortage of it on the ASX. Analysts at Bell Potter have recently named a select group of ASX shares they...

On Friday, the S&P/ASX 200 Index (ASX: XJO) ended the week in the red. The benchmark index dropped 0.8% to 7,646.5 points. Will the market be able to bounce back from this on Monday? Here are five things to watch: ASX 200 expected to...

Donald Trump’s latest tariff bombshell has shaken global markets and it’s raising serious questions. Was this chaos just bad policy… or something more calculated? Listen to the HotCopper podcast for in-depth discussions and insights on a...

Highlights: Financial sector unchanged by midday as broader market trends lower Regal Partners reports a decline in funds under management over the quarter Healthcare sector leads losses amid tariff concerns and industry dev...

Highlights: ASX lifts sharply with all sectors closing higher, rebounding from prior session declines Nikkei records strong movement as markets respond to tariff rhetoric Resource and tech firms lead gains, while a few small...

ASX rallies 2.27% after shedding 4% yesterday Nikkei225 soars almost 6%, recovering from Monday’s losses Trade war threatens to escalate as China calls tariff escalations ‘a mistake’.   The ASX posted a strong gain to rise 2.27% today, re...

It was a stunning recovery day for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Tuesday. After the carnage that kicked off the trading week yesterday, investors were clearly in the mo...

Highlights: ASX index experiences its heaviest single-day loss since the early pandemic period Commodity prices, including gold and copper, decline sharply as global markets reel Buyout proposal drives significant gains for...

Companies including Cochlear and Telix affirm that tariffs are likely to be a ‘Y2K’ non-event Bell Potter says Trajan shares are worth double their current price Plucky Biotron lives another day after passing the hat   On the evening of D...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Tariff rumours whipsawed the S&P500 over an 8.5% range from trough-to-peak over...

Highlights: Lynas Rare Earths and Nyrada advanced while most sectors declined Abacus Storage King surged following a major acquisition proposal Woodside Energy and Kelsian Group posted declines despite business developments...

The ASX200 closed down 4.2% at 7,343 points in a $97B wipeout for the market. The Energy sector was decimated, down 7%, followed by Financials, down 5%, and Materials and Discretionary – both down 4.8%. In the Green Lynas Rare News...

ASX tanks 4pc, worst drop since may 2020 Gold, copper, Bitcoin hammered in global rout Abacus Storage King bursts up after receiving buyout proposal    The ASX has taken a big hit on Monday, dropping by 4% as it marked the worst one-day l...

The ASX 200 index is crashing on Monday following an equally brutal selloff on Wall Street on Friday. While it certainly is a tough time for ASX investors, it could also be one of the best buying opportunities we have had in years and an id...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, April 7, 2025 /PRNewswire/ — Telix Pharmac...

The recent share market selloff has rattled investor confidence — but for those thinking long term, it could be a gift in disguise. When share prices drop across the board, it often has less to do with company fundamentals and more to do...

If you are looking for ASX 200 stocks to buy in April after recent weakness, then it could be worth listening to what analysts at Bell Potter are saying. That's because the broker has just revealed its favoured picks for the month ahead o...

Donald Trump exempts “pharmaceuticals” from his tariff blitz ASX device makers mull their US manufacturing plans as Ansell shares plunge Race and Imugene progress their early-stage oncology trials   Liberation Day has spared the pharmaceu...

If you're looking to invest in the next generation of ASX success stories, sometimes you need to look beyond the usual household names. While the big end of town offers stability, it's often the mid-caps and emerging leaders that deliver th...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, April 2, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited...

Some investors contend Clinuvel’s mountain of $200 million of cash is excessive and amounts to a ‘lazy’ balance sheet The company argues the cash buffer protects it against unexpected adversities and – in any event – every cent will be nee...

I think it is fair to say that 2025 hasn't exactly started the way most investors were hoping. Trade tensions, market jitters, and a sharp selloff in growth and tech stocks have sent many ASX shares tumbling well off their highs. And while...

Despite a late upturn, the ASX 200 closed 0.38% in the red on Thursday Blame factor 1: Trump and his 25% US auto import tariffs, set to come into play early April Blame factor 2: A Wall Street tech rout, which Trump had a hand in, too   ...

A cabal of ASX drug developers has defied the US gloom The healthcare jury’s out on new FDA head Dr Marty Makary Emvision’s Emu trial takes flight Amid the downbeat narrative about US healthcare policy and cuts to funding agencies, a ‘Mag...

The team at Bell Potter has been busy running the rule over the healthcare sector and has picked out a number of stocks that it believes are attractive options right now. Let's see what the broker is recommending investors buy now: Clinuve...